Neurocrine Biosciences, Inc.: Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

VYKAT XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy Expands ...
Indiatimes

Diabetic drug metformin found to act on brain

NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had imagined — by acting directly ...
The Malaysian Reserve

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative ...
Healio

Diabetic Macular Edema: Rethinking Response and Revising Treatment With Corticosteroid Therapy

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Despite major therapeutic advances, diabetic macular ...
Utusan Malaysia

Innovent’s Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration ...

OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to ...
Hosted on MSN

Scientists discover popular diabetic drug's unexpected effect on the brain

For 60 years, metformin has been the go-to medication to manage type 2 diabetes. It is known for lowering blood sugar, however, there is no complete picture of how it really works. Scientists have now ...